The question here is simple: which parts of this product are genuinely hard, and which parts are mostly a very profitable coordination habit?
heated-tobacco system
IQOS is PMI's flagship heated-tobacco platform that uses electronic devices and tobacco sticks to deliver nicotine without combusting tobacco.
IQOS is central to PMI's claim that it can preserve nicotine demand while moving users away from cigarettes and into a proprietary smoke-free ecosystem.
Replacement sketch
Alternatives
These alternatives are not always drop-in replacements. They do, however, show where the incumbent's pricing power starts facing open pressure.
Disruptive concepts
These are not just existing alternatives. They are structured product ideas for how open coordination, Bitcoin rails, or decentralized production could attack the incumbent's capture points.
IQOS remains a regulated heated-tobacco product used to deliver addictive nicotine. FDA materials emphasize that heated tobacco products are not safe or FDA-approved in the everyday sense, and the most credible harm-reduction alternative for many users is quitting or using approved nicotine replacement therapy rather than an open or decentralized heated-tobacco substitute.
Technology waves
These are the repo's explicit bias terms: the technologies expected to keep making incumbents less inevitable over time.
Sources
Primary company source describing IQOS and ZYN, including category positioning and shipment or user claims.
FDA source explaining the specific reduced-exposure claims allowed for IQOS and clarifying the regulatory framing.
FDA authorization context for additional heated tobacco products used with the IQOS device.
FDA health and cessation context covering nicotine addiction, heated tobacco risk positioning, and approved NRT alternatives.